RSS   Newsletter   Contact   Advertise with us
Post Online Media

uniQure appoints Jonathan Garen as chief business officer

uniQureuniQure N.V., a human gene therapy company, announced the appointment of Jonathan Garen as chief business officer.

Mr. Garen has more than 20 years of experience in business development within the pharmaceutical sector, having previously held senior positions at Actavis plc, Forest Laboratories, Inc. and Pharmacia Corporation.

Mr. Garen was most recently with Syros Pharmaceuticals, Inc., a venture-backed company developing medicines that control genes, where he served as Chief Business Officer.

Prior to joining Syros, he was Assistant Vice President, Business Development at Forest Laboratories, Inc. from 2003 to 2014, and subsequently held the same position at Actavis plc following its acquisition of Forest Laboratories.

Earlier in his career, Mr. Garen was Director of Global Licensing with Pharmacia Corporation and a Founder and Vice President of Technology Exchange, Inc.

Mr. Garen holds a Master of Environmental Science degree from Yale University and a Bachelor of Science degree in Physics from Massachusetts Institute of Technology.


 LATEST MOVES FROM the Netherlands 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy